These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9857350)

  • 1. Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon-alpha.
    Habersetzer F; Zoulim F; Jusot JF; Zhang X; Trabaud MA; Chevallier P; Chevallier M; Ahmed SN; Sepetjan M; Comanor L; Minor J; Trépo C
    J Viral Hepat; 1998 Nov; 5(6):407-14. PubMed ID: 9857350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the nucleic acid-based crosslinking hybridization assay and the branched DNA signal amplification assay in the quantitative measurement of serum hepatitis B virus DNA.
    Hwang SJ; Lu RH; Wood ML; Wang YJ; Chang FY; Lee SD
    J Clin Lab Anal; 1999; 13(6):296-300. PubMed ID: 10633298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea.
    Yoo BC; Park JW; Kim HJ; Lee DH; Cha YJ; Park SM
    J Hepatol; 2003 Jan; 38(1):98-103. PubMed ID: 12480566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ; Yoo BC
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential analysis of hepatitis B virus core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment.
    Zampino R; Marrone A; Cirillo G; del Giudice EM; Utili R; Karayiannis P; Liang TJ; Ruggiero G
    J Viral Hepat; 2002 May; 9(3):183-8. PubMed ID: 12010505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients.
    Guptan RC; Thakur V; Kazim SN; Sarin SK
    J Gastroenterol Hepatol; 2002 Jul; 17(7):765-71. PubMed ID: 12121506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose recombinant interferon therapy in anti-HBe-positive chronic hepatitis B in Asian Indians.
    Guptan RC; Thakur V; Malhotra V; Sarin SK
    J Gastroenterol Hepatol; 1998 Jul; 13(7):675-9. PubMed ID: 9715416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Valdes A; Galimany R; Esteban R; Guardia J
    J Viral Hepat; 2001 Nov; 8(6):465-71. PubMed ID: 11703579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.
    Chen RY; Bowden S; Desmond PV; Dean J; Locarnini SA
    J Gastroenterol Hepatol; 2003 Jun; 18(6):630-7. PubMed ID: 12753143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.
    Nafa S; Ahmed S; Tavan D; Pichoud C; Berby F; Stuyver L; Johnson M; Merle P; Abidi H; Trépo C; Zoulim F
    Hepatology; 2000 Nov; 32(5):1078-88. PubMed ID: 11050059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of changes in serum hepatitis B virus DNA titer in patients with chronic hepatitis B treated with interferon.
    Hwang SJ; Lu RH; Wang YJ; Chu CW; Wu JC; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):1-7. PubMed ID: 10645044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B].
    Yoo BC; Kim HJ; Do JH; Park SM
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):381-8. PubMed ID: 12506242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic variations in precore and cytotoxic T lymphocyte regions in chronic hepatitis B in relationship to interferon responsiveness.
    Shindo M; Okuno T
    Liver; 2000 Apr; 20(2):136-42. PubMed ID: 10847482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification assay in Taiwan.
    Dai CY; Yu ML; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chuang WL; Chang WY
    J Clin Pathol; 2004 Feb; 57(2):141-5. PubMed ID: 14747437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy.
    Chan HL; Leung NW; Lau TC; Wong ML; Sung JJ
    J Clin Microbiol; 2000 Sep; 38(9):3205-8. PubMed ID: 10970358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy.
    Tseng TC; Yu ML; Liu CJ; Lin CL; Huang YW; Hsu CS; Liu CH; Kuo SF; Pan CJ; Yang SS; Su CW; Chen PJ; Chen DS; Kao JH
    Antivir Ther; 2011; 16(5):629-37. PubMed ID: 21817184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B.
    Lok AS; Ghany MG; Watson G; Ayola B
    J Viral Hepat; 1998 May; 5(3):171-8. PubMed ID: 9658370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.
    Tangkijvanich P; Komolmit P; Mahachai V; Sa-nguanmoo P; Theamboonlers A; Poovorawan Y
    J Clin Virol; 2009 Oct; 46(2):117-23. PubMed ID: 19651540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peginterferon-α2a combined with response-guided short-term lamivudine improves response rate in hepatitis B e antigen-positive hepatitis B patients: a pilot study.
    Huang Z; Deng H; Zhao Q; Zheng Y; Peng L; Lin C; Zhao Z; Gao Z
    Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1165-9. PubMed ID: 23571612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection.
    Marrone A; Zampino R; Luongo G; Utili R; Karayiannis P; Ruggiero G
    Intervirology; 2003; 46(4):222-6. PubMed ID: 12931030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.